2-178784339-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001267550.2(TTN):c.2506G>A(p.Gly836Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.2506G>A | p.Gly836Ser | missense_variant | Exon 16 of 363 | ENST00000589042.5 | NP_001254479.2 | |
TTN | NM_133379.5 | c.2506G>A | p.Gly836Ser | missense_variant | Exon 16 of 46 | ENST00000360870.10 | NP_596870.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.2506G>A | p.Gly836Ser | missense_variant | Exon 16 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 | ||
TTN | ENST00000360870.10 | c.2506G>A | p.Gly836Ser | missense_variant | Exon 16 of 46 | 5 | NM_133379.5 | ENSP00000354117.4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 249958Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135228
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461742Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727166
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
- -
not specified Uncertain:1
Variant summary: TTN c.2506G>A (p.Gly836Ser) results in a non-conservative amino acid change located in the region near Z-disk of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 249958 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2506G>A has been reported in the literature in an individual with sudden unexplained death (Modena_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. Co-occurrences with other pathogenic variant(s) have been reported ( MYBPC3 c.3624delC , p.Lys1209SerfsX28), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 32101375). ClinVar contains an entry for this variant (Variation ID: 597613). Based on the evidence outlined above, the variant was classified as uncertain significance. -
TTN-related disorder Uncertain:1
The TTN c.2506G>A variant is predicted to result in the amino acid substitution p.Gly836Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.010% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Uncertain:1
The p.G790S variant (also known as c.2368G>A), located in coding exon 14 of the TTN gene, results from a G to A substitution at nucleotide position 2368. The glycine at codon 790 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at